Gerresheimer acquires Vedat

NewsGuard 100/100 Score

Gerresheimer AG, one of the leading worldwide suppliers to the pharma and healthcare industry, has acquired the Brazilian company Vedat to strengthen its pharmaceutical plastic packaging business in South America. Vedat is a major Brazilian manufacturer of pharmaceutical plastic packaging products, especially plastic closures.

"Expanding in emerging markets is a key component of our growth strategy. The acquisition of Vedat, a technology leader and very profitable company in Brazil, is significantly strengthening our position in the South American pharmaceutical primary packaging market. It perfectly fits our strategy of doubling our sales in the emerging markets from EUR 100 million to EUR 200 million by 2013," commented Uwe Rohrhoff, CEO of Gerresheimer AG.

Vedat has an excellent positioning in the South American market for pharmaceutical plastic packaging. Its product portfolio comprises plastic closures, PET bottles and other plastic containers and the majority of its customers are in the South American pharmaceutical industry. Gerresheimer already manufactures pharmaceutical plastic packaging and medical plastic systems for the South American market at three plants in Brazil and one plant in Argentina.

"Now that we have the combination of bottles and closures, we can provide a fully comprehensive range of products and services to our South American pharmaceutical customers on a one stop shop basis. Vedat will help us to take an important step forward as a full-service partner for pharmaceutical plastic packaging in South America," added Uwe Rohrhoff.

Vedat, located in Sao Paolo, Brazil, generated annual sales of BRL 106 million (approximately EUR 45 million) in 2010 and it employs approx-imately 450 people.

SOURCE Gerresheimer AG

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can generative AI truly transform healthcare into a more personalized experience?